vs

Side-by-side financial comparison of BT Brands, Inc. (BTBD) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

BT Brands, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.0M, roughly 1.9× Roivant Sciences Ltd.). BT Brands, Inc. runs the higher net margin — 23.7% vs -13301.2%, a 13324.9% gap on every dollar of revenue. On growth, BT Brands, Inc. posted the faster year-over-year revenue change (-11.4% vs -77.8%). BT Brands, Inc. produced more free cash flow last quarter ($261.8K vs $-201.4M). Over the past eight quarters, BT Brands, Inc.'s revenue compounded faster (-1.8% CAGR vs -73.7%).

BT Group plc is a British multinational telecommunications holding company headquartered in London, England. It has operations in around 180 countries and is the largest provider of fixed-line, broadband and mobile services in the UK, and also provides subscription television and IT services.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

BTBD vs ROIV — Head-to-Head

Bigger by revenue
BTBD
BTBD
1.9× larger
BTBD
$3.9M
$2.0M
ROIV
Growing faster (revenue YoY)
BTBD
BTBD
+66.4% gap
BTBD
-11.4%
-77.8%
ROIV
Higher net margin
BTBD
BTBD
13324.9% more per $
BTBD
23.7%
-13301.2%
ROIV
More free cash flow
BTBD
BTBD
$201.7M more FCF
BTBD
$261.8K
$-201.4M
ROIV
Faster 2-yr revenue CAGR
BTBD
BTBD
Annualised
BTBD
-1.8%
-73.7%
ROIV

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
BTBD
BTBD
ROIV
ROIV
Revenue
$3.9M
$2.0M
Net Profit
$915.0K
$-265.9M
Gross Margin
Operating Margin
19.1%
-16966.1%
Net Margin
23.7%
-13301.2%
Revenue YoY
-11.4%
-77.8%
Net Profit YoY
516.9%
-257.0%
EPS (diluted)
$0.15
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTBD
BTBD
ROIV
ROIV
Q4 25
$2.0M
Q3 25
$3.9M
$1.6M
Q2 25
$3.8M
$2.2M
Q1 25
$3.2M
$-39.6M
Q4 24
$9.0M
Q3 24
$4.3M
$4.5M
Q2 24
$4.1M
$8.0M
Q1 24
$3.2M
$28.9M
Net Profit
BTBD
BTBD
ROIV
ROIV
Q4 25
$-265.9M
Q3 25
$915.0K
$-113.5M
Q2 25
$55.0K
$-223.4M
Q1 25
$-329.8K
$-206.5M
Q4 24
$169.4M
Q3 24
$-219.5K
$-230.2M
Q2 24
$-70.0K
$95.3M
Q1 24
$-445.7K
$-151.1M
Operating Margin
BTBD
BTBD
ROIV
ROIV
Q4 25
-16966.1%
Q3 25
19.1%
-19492.9%
Q2 25
-2.0%
-13130.0%
Q1 25
-9.0%
674.8%
Q4 24
-3042.6%
Q3 24
-1.7%
-7636.0%
Q2 24
-4.6%
-1279.5%
Q1 24
-19.8%
-919.5%
Net Margin
BTBD
BTBD
ROIV
ROIV
Q4 25
-13301.2%
Q3 25
23.7%
-7225.9%
Q2 25
1.5%
-10292.9%
Q1 25
-10.2%
521.8%
Q4 24
1878.3%
Q3 24
-5.0%
-5143.8%
Q2 24
-1.7%
1192.7%
Q1 24
-14.0%
-522.3%
EPS (diluted)
BTBD
BTBD
ROIV
ROIV
Q4 25
$-0.38
Q3 25
$0.15
$-0.17
Q2 25
$-0.33
Q1 25
$-0.28
Q4 24
$0.23
Q3 24
$-0.04
$-0.31
Q2 24
$0.12
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTBD
BTBD
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$3.5M
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$7.7M
$4.3B
Total Assets
$11.9M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTBD
BTBD
ROIV
ROIV
Q4 25
$4.5B
Q3 25
$3.5M
$4.4B
Q2 25
$3.0M
$4.5B
Q1 25
$2.7M
$4.9B
Q4 24
$5.1B
Q3 24
$2.0M
$5.4B
Q2 24
$1.5M
$5.7B
Q1 24
$1.5M
$6.5B
Total Debt
BTBD
BTBD
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
BTBD
BTBD
ROIV
ROIV
Q4 25
$4.3B
Q3 25
$7.7M
$4.4B
Q2 25
$6.8M
$4.3B
Q1 25
$6.7M
$4.7B
Q4 24
$5.2B
Q3 24
$8.5M
$5.2B
Q2 24
$8.7M
$5.4B
Q1 24
$8.8M
$6.0B
Total Assets
BTBD
BTBD
ROIV
ROIV
Q4 25
$5.2B
Q3 25
$11.9M
$5.1B
Q2 25
$11.2M
$5.0B
Q1 25
$11.0M
$5.4B
Q4 24
$5.8B
Q3 24
$13.7M
$6.2B
Q2 24
$14.0M
$6.5B
Q1 24
$14.0M
$7.2B
Debt / Equity
BTBD
BTBD
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTBD
BTBD
ROIV
ROIV
Operating Cash FlowLast quarter
$325.2K
$-196.5M
Free Cash FlowOCF − Capex
$261.8K
$-201.4M
FCF MarginFCF / Revenue
6.8%
-10076.0%
Capex IntensityCapex / Revenue
1.6%
246.9%
Cash ConversionOCF / Net Profit
0.36×
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTBD
BTBD
ROIV
ROIV
Q4 25
$-196.5M
Q3 25
$325.2K
$-185.7M
Q2 25
$384.4K
$-204.4M
Q1 25
$-306.7K
$-172.6M
Q4 24
$-207.3M
Q3 24
$129.3K
$-266.8M
Q2 24
$82.5K
$-192.8M
Q1 24
$-408.9K
$-108.5M
Free Cash Flow
BTBD
BTBD
ROIV
ROIV
Q4 25
$-201.4M
Q3 25
$261.8K
$-193.5M
Q2 25
$-208.4M
Q1 25
$-431.1K
$-173.4M
Q4 24
$-209.1M
Q3 24
$50.4K
$-267.8M
Q2 24
$53.7K
$-193.8M
Q1 24
$-521.3K
$-108.8M
FCF Margin
BTBD
BTBD
ROIV
ROIV
Q4 25
-10076.0%
Q3 25
6.8%
-12317.8%
Q2 25
-9604.5%
Q1 25
-13.3%
438.1%
Q4 24
-2318.5%
Q3 24
1.2%
-5984.4%
Q2 24
1.3%
-2425.5%
Q1 24
-16.3%
-376.1%
Capex Intensity
BTBD
BTBD
ROIV
ROIV
Q4 25
246.9%
Q3 25
1.6%
499.6%
Q2 25
0.0%
185.9%
Q1 25
3.8%
-2.0%
Q4 24
20.3%
Q3 24
1.8%
22.3%
Q2 24
0.7%
12.1%
Q1 24
3.5%
1.2%
Cash Conversion
BTBD
BTBD
ROIV
ROIV
Q4 25
Q3 25
0.36×
Q2 25
6.98×
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons